These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. Schaefer WH; Lawrence JW; Loughlin AF; Stoffregen DA; Mixson LA; Dean DC; Raab CE; Yu NX; Lankas GR; Frederick CB Toxicol Appl Pharmacol; 2004 Jan; 194(1):10-23. PubMed ID: 14728975 [TBL] [Abstract][Full Text] [Related]
27. Diminished force production and mitochondrial respiratory deficits are strain-dependent myopathies of subacute limb ischemia. Schmidt CA; Ryan TE; Lin CT; Inigo MMR; Green TD; Brault JJ; Spangenburg EE; McClung JM J Vasc Surg; 2017 May; 65(5):1504-1514.e11. PubMed ID: 28024849 [TBL] [Abstract][Full Text] [Related]
29. Mitochondrial myopathies. DiMauro S; Bonilla E; Zeviani M; Nakagawa M; DeVivo DC Ann Neurol; 1985 Jun; 17(6):521-38. PubMed ID: 3927817 [TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle metabolism as a target for drug therapy in peripheral arterial disease. Brass EP Vasc Med; 1996; 1(1):55-9. PubMed ID: 9546916 [TBL] [Abstract][Full Text] [Related]
31. Skeletal muscle mitochondrial function and exercise capacity are not impaired in mice with knockout of STAT3. Dent JR; Hetrick B; Tahvilian S; Sathe A; Greyslak K; LaBarge SA; Svensson K; McCurdy CE; Schenk S J Appl Physiol (1985); 2019 Oct; 127(4):1117-1127. PubMed ID: 31513449 [TBL] [Abstract][Full Text] [Related]
32. Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat. Warren BE; Lou PH; Lucchinetti E; Zhang L; Clanachan AS; Affolter A; Hersberger M; Zaugg M; Lemieux H Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E658-67. PubMed ID: 24425766 [TBL] [Abstract][Full Text] [Related]
33. Carnitine and peripheral arterial disease. Hiatt WR Ann N Y Acad Sci; 2004 Nov; 1033():92-8. PubMed ID: 15591006 [TBL] [Abstract][Full Text] [Related]
34. Familial "mitochondrial" myopathy. A myopathy associated with disordered oxidative metabolism in muscle fibres. 2. Biochemical findings. Worsfold M; Park DC; Pennington RJ J Neurol Sci; 1973 Jul; 19(3):261-74. PubMed ID: 4716844 [No Abstract] [Full Text] [Related]
35. Mitochondria-lipid-glycogen myopathy, hyperlactacidemia, and carnitine deficiency. Di Donato S; Cornelio F; Balestrini MR; Bertagnolio B; Peluchetti D Neurology; 1978 Nov; 28(11):1110-6. PubMed ID: 568729 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives. Marra AM; Arcopinto M; Bossone E; Ehlken N; Cittadini A; GrĂ¼nig E Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):131-9. PubMed ID: 25455722 [TBL] [Abstract][Full Text] [Related]
37. Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics. Berru FN; Gray SE; Thome T; Kumar RA; Salyers ZR; Coleman M; Dennis Le ; O'Malley K; Ferreira LF; Berceli SA; Scali ST; Ryan TE Sci Rep; 2019 Oct; 9(1):15547. PubMed ID: 31664123 [TBL] [Abstract][Full Text] [Related]
38. Impaired muscle relaxation and mitochondrial fission associated with genetic ablation of cytoplasmic actin isoforms. O'Rourke AR; Lindsay A; Tarpey MD; Yuen S; McCourt P; Nelson DM; Perrin BJ; Thomas DD; Spangenburg EE; Lowe DA; Ervasti JM FEBS J; 2018 Feb; 285(3):481-500. PubMed ID: 29265728 [TBL] [Abstract][Full Text] [Related]
39. Nuclear receptors as potential therapeutic targets in peripheral arterial disease and related myopathy. Kumar A; Narkar VA FEBS J; 2023 Oct; 290(19):4596-4613. PubMed ID: 35942640 [TBL] [Abstract][Full Text] [Related]
40. Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy. Gehrig SM; Mihaylova V; Frese S; Mueller SM; Ligon-Auer M; Spengler CM; Petersen JA; Lundby C; Jung HH Orphanet J Rare Dis; 2016 Jul; 11(1):105. PubMed ID: 27473873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]